No CRS summary available for this bill.
This section states congressional findings on breast and cervical cancer, including an estimated 319,750 new cases and 43,000 deaths from invasive breast cancer and 13,360 new cases and 4,320 deaths from invasive cervical cancer in 2025. The section further finds that the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)—which provides screening and diagnostic services with outreach emphasis to low-income, uninsured, underinsured, and geographically or culturally isolated women—has screened over 6.4 million people, provided over 16.5 million examinations, and diagnosed nearly 80,000 invasive breast cancers, over 25,000 premalignant breast lesions, 5,300 invasive cervical cancers, and 248,000 premalignant cervical lesions (38% high-grade) since 1991; reauthorizing NBCCEDP, the section finds, will expand services, screenings, and early-stage diagnoses.
This section revises the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)—which provides CDC grants to states for breast and cervical cancer screening, diagnostics, and follow-up for low-income, uninsured, or underinsured women—as follows: (1) in section 1501 (42 U.S.C. 300k), expands authorized services to emphasize prevention activities; requires provision of appropriate follow-up services; adds new services to enhance screening support activities (e.g., patient navigation, evidence-based strategies), reduce disparities in incidence and mortality, and improve equitable access by addressing barriers; and strikes subsection (d); (2) in section 1503 (42 U.S.C. 300m), replaces requirements in subsection (a)(1) to expend at least 60% of grants on core screening services (paras. (1)-(2) of section 1501(a)), conduct specific mammography and Pap smear procedures, provide all services by the end of year two, and limit expenditures on other services to 40%, with a requirement to provide appropriate screening and diagnostic services consistent with evidence-based recommendations and all services by the end of year two; strikes former paragraphs (a)(2) and (a)(4); and eliminates the demonstration waiver project under subsection (d) for up to five states to leverage nonfederal funds; (3) in section 1508(b) (42 U.S.C. 300n–4(b)), revises reporting requirements from annually beginning one year after the 2007 reauthorization (covering the preceding fiscal year) to every five years beginning two years after enactment of this Act (covering the preceding two fiscal years for the first report and five fiscal years thereafter), and updates the responsible Senate committee to Health, Education, Labor, and Pensions (from Labor and Human Resources); and (4) in section 1510(a) (42 U.S.C. 300n–5(a)), authorizes $235 million annually for NBCCEDP for FY2026 through FY2030 (previously authorized through FY2011).
This section directs the Comptroller General of the United States to submit a report to the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce by September 30, 2027, on the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). (As background, the NBCCEDP provides breast and cervical cancer screenings, diagnostic services, and patient navigation to low-income, uninsured, and underinsured women.) The report must include (1) an estimate of the number of individuals eligible for services under the program; (2) a summary of trends in the number of individuals served; and (3) an assessment of factors driving those trends, including barriers to accessing screenings.